AS

Alexander Schuth

Chief Operating and Financial Officer

Denali Therapeutics

San Francisco, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Denali Therapeutics
Industry
research
Employees
520.0
Seniority
C suite
Annual Revenue
330530000.0

Professional Summary

Alexander Schuth serves as Chief Operating and Financial Officer at Denali Therapeutics. Denali Therapeutics operates in the research sector with approximately 520.0 employees. The company is headquartered in San Francisco, California. Denali Therapeutics generates annual revenue of 330530000.0.

Industry & Role Insights

  • MessageCEO tracks 2,961 executives in the research sector.
  • We have verified contacts for 2 executives at Denali Therapeutics.
  • 13,742 executive contacts are available in California.
  • Our database includes 201,467 c suite-level executives.

Technologies

CloudFlare Hosting Salesforce Gmail Outlook Google Apps MailChimp SPF Microsoft Office 365 Greenhouse.io Amazon AWS Drupal React Adobe Marketing Cloud Google Tag Manager YouTube New Relic Typekit Segment.io Mobile Friendly Google Analytics Sigma Remote Circle

Keywords

biotechnology neurodegenerative disease neurodegeneration pharmaceuticals biotechnology: biological products (no diagnostic substances) health care biotechnology research neurodegenerative diseases therapeutic discovery blood-brain barrier biomarker-driven development clinical trials genetic pathways molecular therapeutics patient community alzheimer's disease parkinson's disease als frontotemporal dementia lysosomal storage diseases dnl310 technology engineered therapeutics drug candidates biotechnological innovations brain delivery systems crossing the blood-brain barrier target engagement pathway engagement patient phenotyping clinical development strategy therapeutics for mps ii therapeutics for mps iiia glial biology therapeutics targeting lrrk2 cellular homeostasis ripk1 inhibitors biologics for neurodegeneration small molecules for brain diseases patient partnering drug manufacturing quality assurance early clinical development preclinical studies therapeutic candidates clinical pipeline collaborations in neuroscience science-driven medicine investor relations scientific publications technological platforms partnering opportunities regulatory compliance clinical research biostatistics healthcare outcomes scientific advisory board innovative therapies biopharmaceuticals enzyme transport vehicles antibody transport vehicles protein transport vehicles oligonucleotide transport vehicles amyotrophic lateral sclerosis (als) hunter syndrome sanfilippo syndrome clinical-stage patient-centric approach scientific rigor transformative medicines unmet medical needs proprietary technology drug delivery healthcare providers patient communities market potential strategic partnerships cns diseases competitive landscape breakthrough therapy designation biologics license application (bla) commercial launch readiness therapeutic pipeline medical health wellness & fitness hospital & health care

Related Executives

SN
Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.
SD
Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.
M
Mark Chief Executive Officer at 23Strands
IT
Ilia Tikhomirov Chief Executive Officer at 35Pharma
AD
Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Alexander Schuth in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Denali Therapeutics.

Alexander Schuth's Position in the MessageCEO Database

  • Alexander Schuth is 1 of 1 verified executive contact we track at Denali Therapeutics.
  • 2,871 verified executive contacts in research are in the MessageCEO database.
  • 12,900 verified executive contacts in California are in the database.
  • 19 verified contacts work at research companies in the 520.0 employee range (same size as Denali Therapeutics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated August 2026.

Frequently Asked Questions

How do I reach Alexander Schuth directly?

Alexander Schuth's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Operating and Financial Officer at Denali Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Alexander Schuth work for?

Alexander Schuth is Chief Operating and Financial Officer at Denali Therapeutics, a company in the research sector with 520.0 employees. The company is based in San Francisco, California.

Can I pitch or sell to Alexander Schuth?

As Chief Operating and Financial Officer at Denali Therapeutics, Alexander Schuth is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Alexander Schuth directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Alexander Schuth in?

Alexander Schuth works in the research industry as Chief Operating and Financial Officer at Denali Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Alexander Schuth's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Alexander Schuth's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: August 14, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans